Steven M Paul's Net Worth
$72.1 Million
Estimate Recalculated Nov 11, 2024 02:36AM EST
Who is Steven M Paul?
Steven M Paul has an estimated net worth of $72.1 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., LILLY ELI & CO, Voyager Therapeutics, Inc., Karuna Therapeutics, Inc., Sage Therapeutics, Inc., SIGMA ALDRICH CORP, and Rapport Therapeutics, Inc..
SEC CIK
Steven M Paul's CIK is 0001237564
Past Insider Trading and Trends
2005 was Steven M Paul's most active year for acquiring shares with 6 total transactions. Steven M Paul's most active month to acquire stocks was the month of May. 2015 was Steven M Paul's most active year for disposing of shares, totalling 17 transactions. Steven M Paul's most active month to dispose stocks was the month of January. 2007 saw Steven M Paul paying a total of $7,173,634.40 for 133,240 shares, this is the most they've acquired in one year. In 2024 Steven M Paul cashed out on 2,643,585 shares for a total of $783,553,993.59, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $246.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$91.01 | -$2,390,420.82 | 1K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
$74.65 | -$1,960,500.00 | 1K |
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
$72.33 | -$3,459,900.00 | 1K |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 1K |
$95.00 | $95,000.00 | 1K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
| No matching records found | |||||||||
LILLY ELI & CO (LLY) Snapshot price: $900.9999
EVP, Science and Technology
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +677.94% | 33.9K |
$35.20 | -$610,790.40 | 38.9K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| -26.64% | -15.40K |
$36.82 | -$567,101.64 | 42.41K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
| -38.13% | -31.00K |
$51.57 | -$1,598,565.78 | 50.3K |
Feb 1 - Feb 4
| |||
Form 4
| +119.48% | 44.26K |
$50.74 | $2,245,549.44 | 81.3K |
Jan 25
| |||
Form 4
| -100.00% | -3.16K |
$54.09 | -$171,086.67 |
0
|
Jul 31
| |||
Form 4
| -2.74% | -1.23K |
$58.62 | -$71,868.12 | 43.48K |
Jun 1
| |||
Form 4
| +11.39% | 4.57K |
$57.20 | -$197,887.60 | 44.7K |
May 21
| |||
Form 4
| +0.23% | 92 |
$57.20 | -$4,078.40 | 40.13K |
May 15
| |||
Form 4
| -87.20% | -7.29K |
$52.39 | -$381,870.71 | 1.07K |
Scheduled
|
Mar 12
| ||
Form 4
| -13.09% | -7.29K |
$54.38 | -$396,430.20 | 48.4K |
Feb 9 - Feb 12
| |||
Form 4
| -15.60% | -10.09K |
$54.32 | -$548,233.52 | 54.62K |
Feb 8
| |||
Form 4
| -9.74% | -6.99K |
$54.12 | -$378,028.20 | 64.71K |
Feb 1
| |||
Form 4
| +80.79% | 32.04K |
$52.86 | $1,693,634.40 | 71.7K |
Jan 17
| |||
Form 4
| -10.61% | -4.84K |
$56.91 | -$275,216.76 | 40.73K |
Sep 15 - Oct 20
| |||
Form 4
| +2.70% | 1.07K |
$44.92 | -$557.25 | 40.73K |
Sep 15
| |||
Form 4
| -38.67% | -25.00K |
$52.06 | -$1,301,507.00 | 39.66K |
Apr 25
| |||
Form 4
| -27.88% | -25.00K |
$52.80 | -$1,320,000.00 | 64.66K |
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -6.47% | -6.20K |
$57.00 | -$353,457.00 | 89.66K |
Feb 2
| |||
Form 4
| -2.84% | -2.80K |
$56.62 | -$158,479.38 | 95.86K |
Feb 1
| |||
Form 4
| +27.97% | 21.56K |
$57.04 | $1,230,010.56 | 98.66K |
Jan 20
| |||
Form 4
| +3.84% | 2.96K |
$45.28 | -$114,519.10 | 80.05K |
Dec 15
| |||
Form 4
| +17.33% | 11.66K |
$37.98 | -$77,369.10 | 78.97K |
Scheduled
|
May 26 - Oct 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +29.20% | 9K |
$56.79 | $511,110.00 | 39.82K |
Jan 14
| |||
Form 4
| +50.30% | 10.31K |
$39.16 | -$259,757.51 | 30.82K |
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| -25.72% | -10.00K |
$64.87 | -$648,716.00 | 28.88K |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +1.16% | 10K |
$14.07 | $140,690.00 | 872.35K |
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Karuna Therapeutics, Inc. (KRTX) No price found
CSO and President R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -150.96K |
$330.00 | -$49,817,790.00 |
0
|
Mar 18
| |||
Form 4
| +185.11% | 47.38K |
$315.18 | $14,932,598.04 | 72.97K |
Feb 29 - Mar 4
| |||
Form 4
| +297.45% | 31.52K |
$19.03 | $599,675.46 | 42.11K |
Feb 23
| |||
Form 4
| -7.05% | -804.00 |
$317.14 | -$254,980.56 | 10.6K |
Feb 9
| |||
Form 4
| +10.71% | 11.4K |
—
|
—
| 117.89K |
May 27 - Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +2.22% | 2.36K |
$105.86 | $250,264.39 | 108.85K |
Aug 17 - Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
$51.81 | -$30,211,281.73 | 106.48K |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +964.85% | 96.48K |
—
|
—
| 106.48K |
Jul 2
| |||
Form 4
|
∞
| 10K |
$23.04 | $230,424.00 | 10K |
Jun 27 - Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sage Therapeutics, Inc. (SAGE) Snapshot price: $7.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +0.01% | 5 |
$38.17 | $190.84 | 78.54K |
Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 1 |
$43.36 | $43.36 | 1 |
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| -2.06% | -7.88K |
$161.04 | -$1,268,824.01 | 374.05K |
Scheduled
|
Mar 21
| ||
Form 4
| -4.27% | -60.42K |
$161.17 | -$9,744,559.04 | 1.36M |
Scheduled
|
Mar 18 - Mar 20
| ||
Form 4
| -0.34% | -2.60K |
$161.00 | -$418,600.00 | 766.8K |
Scheduled
|
Mar 1
| ||
Form 4
| -0.20% | -2.00K |
$161.00 | -$322,000.00 | 1M |
Scheduled
|
Feb 25
| ||
Form 4
| -4.14% | -51.00K |
$161.38 | -$8,213,583.13 | 1.18M |
Scheduled
|
Feb 1 - Feb 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| -8.42% | -58.14K |
$172.00 | -$9,999,908.00 | 632.71K |
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +0.32% | 2.17K |
$3.15 | $6,848.10 | 690.85K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| -0.11% | -5.08K |
—
|
—
| 4.76M |
Feb 23
| |||
Form 4
| -2.84% | -20.00K |
$52.41 | -$1,048,184.38 | 683.65K |
Scheduled
|
Sep 1
| ||
Form 4
| -2.76% | -20.00K |
$67.08 | -$1,341,691.86 | 703.65K |
Scheduled
|
Aug 3
| ||
Form 4
| -2.69% | -20.00K |
$69.40 | -$1,388,027.64 | 723.65K |
Scheduled
|
Jul 1
| ||
Form 4
| -2.62% | -20.00K |
$72.34 | -$1,446,799.47 | 743.65K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| -2.55% | -20.00K |
$53.31 | -$1,066,200.00 | 763.65K |
Scheduled
|
May 1
| ||
Form 4
| -2.49% | -20.00K |
$48.51 | -$970,200.00 | 783.65K |
Apr 1
| |||
Form 4
| +1.26% | 10K |
$18.00 | $180,000.00 | 803.65K |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||